Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes

Clinical and Experimental Medicine

Volumn 12, Issue 4, 2012, Pages 265-272

  Ozcan, Filiz ^a   Ozmen, Asli ^a   Akkaya, Bahar ^a   Aliciguzel, Yakup ^a   Aslan, Mutay ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Diabetes; Myricetin; Nephropathy

Indexed keywords

GLUTATHIONE PEROXIDASE; MYRICETIN; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY PARENCHYMA; KIDNEY STRUCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ANIMALS; BLOOD UREA NITROGEN; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FLAVONOIDS; HISTOCYTOCHEMISTRY; HYPOGLYCEMIC AGENTS; KIDNEY; METABOLIC CLEARANCE RATE; MICROSCOPY; PROTEINURIA; RATS; RATS, WISTAR; TREATMENT OUTCOME; URINE;

RATTUS; RATTUS NORVEGICUS;

EID: 84870460473     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-011-0167-0     Document Type: Article

References (31)

1. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553 (Pubitemid 28319935)
2. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 233:4-11
3. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164-176 (Pubitemid 40095801)
4. Xu Y, Osborne BW, Stanton RC (2005) Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 289:F1040-F1047 (Pubitemid 41447059)
5. Kowluru RA, Abbas SN, Odenbach S (2004) Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J Diabetes Complications 18:282-288 (Pubitemid 39165435)
6. Kamalakkannan N, Prince PS (2006) Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxicol 98:97-103
7. Ong KC, Khoo HE (1997) Biological effects of myricetin. Gen Pharmacol 29:121-126 (Pubitemid 27312361)
8. Montoro P, Tuberoso CI, Piacente S, Perrone A, De Feo V, Cabras P, Pizza C (2006) Stability and antioxidant activity of polyphenols in extracts of Myrtus communis L. berries used for the preparation of myrtle liqueur. J Pharm Biomed Anal 41:1614-1619 (Pubitemid 44255869)
9. Ong KC, Khoo HE (2000) Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci 67:1695-1705
10. Fabiny DL, Ertingshausen G (1971) Automated reaction-rate method for determination of serum creatinine with the Centrifi-Chem. Clin Chem 17:696-700
11. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
12. Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA (1989) A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med 6:607-615 (Pubitemid 19147811)
13. Aliciguzel Y, Ozen I, Aslan M, Karayalcin U (2003) Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med 142:172-177 (Pubitemid 37260470)
14. Wasowicz W, Nève J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522-2526 (Pubitemid 24008241)
15. Raij L, Azar S, Keane WF (1985) Role of hypertension in progressive glomerular immune injury. Hypertension 7:398-404 (Pubitemid 15228088)
16. Akman S, Kalay S, Akkaya B, Koyun M, Akbaş H, Baysal YE, Guven AG (2009) Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome. Pediatr Nephrol 24:1173-1180
17. The Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions, Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl JMed 342:381-389
18. Kang JJ, Toma I, Sipos A, McCulloch F, Peti-Peterdi J (2006) Quantitative imaging of basic functions in renal (patho) physiology. Am J Physiol Renal Physiol 291:F495-F502 (Pubitemid 44148139)
19. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546 (Pubitemid 34087272)
20. Andreassen TT, Seyer-Hansen K, Oxlund H (1981) Biomechanical changes in connective tissues induced by experimental diabetes. Acta Endocrinol (Copenh) 98:432-436 (Pubitemid 12209452)
21. Ong KC, Khoo HE (1996) Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem Pharmacol 51:423-429 (Pubitemid 26069852)
22. Choi JS, Yokozawa T, Oura H (1991) Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin. Planta Med 57:208-211
23. Blondel O, Bailbe D, Portha B (1990) Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. Metabolism 39:787-793 (Pubitemid 20250989)
24. Shisheva A, Shechter Y (1992) Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes. Biochemistry 31:8059-8063
25. Serradas P, Bailbé D, Blondel O, Portha B (1991) Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments. Pancreas 6:54-62
26. Lavoie L, Dimitrakoudis D, Marette A, Annabi B, Klip A, Vranic M, van de Werve G (1993) Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes 42:363-366 (Pubitemid 23045044)
27. Haneda M, Koya D, Kikkawa R (2001) Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 38:S178-S181 (Pubitemid 32927639)
28. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA (2005) Oxidative-nitrosative stress and poly(ADPribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54:3435-3441 (Pubitemid 43334333)
29. Dave GS, Kalia K (2007) Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Cell Mol Biol (Noisy-le-grand) 53:68-78 (Pubitemid 350164307)
30. Triggiani V, Resta F, Guastamacchia E, Sabbà C, Licchelli B, Ghiyasaldin S, Tafaro E (2006) Role of antioxidants, essential fatty acids, carnitine, vitamins, phytochemicals and trace elements in the treatment of diabetes mellitus and its chronic complications. Endocr Metab Immune Disord Drug Targets 6:77-93 (Pubitemid 43796714)
31. Derosa G, Maffioli P (2010) Effects of thiazolidinediones and sulfonylureas in patients with diabetes. Diabetes Technol Ther 12:491-501